【レポートの概要(一部)】
PART 01:Executive summary
• Highlights
PART 02:Scope of the report
• Market overview
• Top-vendor offerings
PART 03:Market research methodology
• Research methodology
• Economic indicators
PART 04:Introduction
• Key market highlights
PART 05:Pipeline portfolio
• Ulcerative colitis
• Crohn’s disease
• IBS
PART 06:Market landscape
• Global gastrointestinal therapeutics market
PART 07:Market segmentation by disease type
• Overview
PART 08:Global IBD therapeutics market
• Global ulcerative colitis drugs market
• Global Crohn’s disease drugs market
• Market segmentation by molecule type
PART 09:Global IBS therapeutics market
PART 10:Global gastrointestinal OTC drugs market
PART 11:Geographical segmentation
• Global gastrointestinal therapeutics market by geography 2015-2020
• Gastrointestinal therapeutics market in Americas
• Gastrointestinal therapeutics market in EMEA
• Gastrointestinal therapeutics market in APAC
PART 12:Market drivers
• Increasing consumption of biologics
• Tentative approval of late stage molecules
• Development of novel therapies using innovative technologies
• Improved diagnostic tools increasing the treatment-seeking population
PART 13:Impact of drivers
PART 14:Market challenges
• Increased consumption of OTC medications
• Unknown etiology of IBD and IBS
• Discontinuation of drugs under development and from the market
PART 15:Impact of drivers and challenges
PART 16:Market trends
• Patient assistance programs
• Emergence of biosimilars
• Rise in self-medication
• Focus on regenerative medicines
• Strategic alliances and M&A
PART 17:Vendor landscape
• Competitive scenario
• Other prominent vendors
PART 18:Key vendor analysis
• AbbVie
• Johnson & Johnson
• Takeda
• Allergan
• UCB
PART 19:Appendix
• List of abbreviations
PART 20:Explore Technavio
[List of Exhibits]
Exhibit 01:Product offerings
Exhibit 02:Global gastrointestinal therapeutics market: Key buying criteria 2015
Exhibit 03:Global gastrointestinal therapeutics market: Key customer segments
Exhibit 04:Global ulcerative colitis therapeutics market: Pipeline portfolio
Exhibit 05:Global Crohn’s disease therapeutics market: Pipeline portfolio
Exhibit 06:Global IBS therapeutics market: Pipeline portfolio
Exhibit 07:Global gastrointestinal therapeutics market snapshot: Developed and emerging markets 2015
Exhibit 08:Global gastrointestinal therapeutics market: Factors affecting growth 2015 and 2020
Exhibit 09:Approval and patent expiries of top selling biologics
Exhibit 10:Global gastrointestinal therapeutics market 2016-2020 ($ billions)
Exhibit 11:Global gastrointestinal disorder therapeutics market segmentation: Growth cycle analysis
Exhibit 12:Five forces analysis
Exhibit 13:Global gastrointestinal therapeutics market by disease type: Revenue share 2015
Exhibit 14:Global gastrointestinal therapeutics market by disease type: Growth lifecycle analysis
Exhibit 15:Global gastrointestinal therapeutics market by disease type 2015-2020
Exhibit 16:Global IBD therapeutics market by type: Revenue share 2015
Exhibit 17:Global IBD therapeutics market by type 2015-2020
Exhibit 18:Global IBD therapeutics market segmentation: Growth lifecycle analysis
Exhibit 19:Global ulcerative colitis drugs market 2015-2020 ($ billions)
Exhibit 20:Global Crohn’s disease drugs market 2015-2020 ($ billions)
Exhibit 21:Global IBD therapeutics market by molecule type 2015
Exhibit 22:Biologics in global IBD therapeutics market 2015-2020 ($ billions)
Exhibit 23:Small molecules in global IBD therapeutics market 2015-2020 ($ billions)
Exhibit 24:Global IBS therapeutics market 2015-2020 ($ billions)
Exhibit 25:Drugs that underwent Rx-to-OTC switch in the US
Exhibit 26:Global gastrointestinal OTC drugs market 2015-2020 ($ billions)
Exhibit 27:Global gastrointestinal therapeutics market by geography 2015-2020
Exhibit 28:Global gastrointestinal therapeutics market by geography 2015 and 2020
Exhibit 29:Global gastrointestinal therapeutics market by geography 2015-2020 ($ billions)
Exhibit 30:Global gastrointestinal therapeutics market by geography: Market share 2015
Exhibit 31:Global gastrointestinal therapeutics market by geography: Disease type 2015
Exhibit 32:Global gastrointestinal therapeutics market by geography: Market growth lifecycle analysis 2015
Exhibit 33:Global gastrointestinal therapeutics market by country: Revenue and growth rate analysis
Exhibit 34:Opportunity analysis of gastrointestinal therapeutics market in Americas
Exhibit 35:Gastrointestinal therapeutics market in Americas 2015-2020 ($ billions)
Exhibit 36:Opportunity analysis of gastrointestinal therapeutics market in EMEA
Exhibit 37:Gastrointestinal therapeutics market in EMEA 2015-2020 ($ billions)
Exhibit 38:Opportunity analysis of gastrointestinal therapeutics market in APAC
Exhibit 39:Gastrointestinal therapeutics market in APAC 2015-2020 ($ billions)
Exhibit 40:Impact of drivers and challenges on global gastrointestinal therapeutics market
Exhibit 41:Biologics for IBD: market share 2012-2022
Exhibit 42:Few biologics under development for gastrointestinal disorders
Exhibit 43:Impact of drivers
Exhibit 44:Rx-to-OTC switch: Promoters and inhibitors
Exhibit 45:Gastrointestinal therapeutics discontinued from development or market
Exhibit 46:Impact of drivers and challenges
Exhibit 47:Global gastrointestinal therapeutics market: Impact assessment of key trends
Exhibit 48:Gastrointestinal therapeutics with patient assistance programs in US
Exhibit 49:Biosimilars under development for gastrointestinal disorders
Exhibit 50:Regenerative medicines for IBD under development
Exhibit 51:Key vendors ranking 2015
Exhibit 52:Key vendors: Geographical presence
Exhibit 53:Market vendors: Competitive scenario 2015-2020
Exhibit 54:AbbVie: Profile
Exhibit 55:AbbVie: Strength analysis
Exhibit 56:AbbVie: Growth strategy matrix
Exhibit 57:AbbVie: Opportunity assessment
Exhibit 58:AbbVie: YoY growth and revenue of HUMIRA 2012-2014 ($ billions)
Exhibit 59:Johnson & Johnson: Profile
Exhibit 60:Johnson & Johnson: Strength analysis
Exhibit 61:Johnson & Johnson: Growth strategy matrix
Exhibit 62:Johnson & Johnson: Opportunity assessment
Exhibit 63:Johnson & Johnson: YoY revenue and growth rate of Remicade 2013-2015 ($ billions)
Exhibit 64:Johnson & Johnson: YoY revenue and growth rate of Simponi/Simponi Aria 2013-2015 ($ billions)
Exhibit 65:Takeda: Profile
Exhibit 66:Takeda: Strength analysis
Exhibit 67:Takeda: Growth strategy matrix
Exhibit 68:Takeda: Opportunity assessment
Exhibit 69:Allergan: Profile
Exhibit 70:Allergan: Strength analysis
Exhibit 71:Allergan: Growth strategy matrix
Exhibit 72:Allergan: Opportunity assessment
Exhibit 73:Allergan: Revenue of gastrointestinal therapeutics 2015 ($ millions)
Exhibit 74:UCB: Profile
Exhibit 75:UCB: Strength analysis
Exhibit 76:UCB: Growth strategy matrix
Exhibit 77:UCB: Opportunity assessment
【レポート販売概要】
■ タイトル:消化器疾患治療薬の世界市場2016-2020■ 英文:Global Gastrointestinal Therapeutics Market 2016-2020
■ 発行日:2016年9月30日
■ 調査会社:Technavio
■ 商品コード:IRTNTR10476
■ 調査対象地域:グローバル
- 小型・戦術UAV用燃料電池の世界市場2019-2023113 Pages, November 2018 About this market Drones have redefined and enhanced the productivity of numerous industries within a short span of time. The next generation of drones is envisioned to be powered by artificial intelligence. Aerial AI is capturing loads of data on a real-time basis, opening a new world for looking over complex physical structures and analyzing the captured data for defects …
- タンパク質シーケンシングの世界市場予測(~2023年)“Global protein sequencing market to register a CAGR of 3.3% from 2018 to 2023” The global protein sequencing market is projected to reach USD 1,088 million by 2023 from USD 925 million in 2018, at a CAGR of 3.3% during the forecast period. Factors such as financial support from government and private bodies for proteomic research, advancements in clinical mass spectrometry and analytical techniqu …
- スピア型攻撃の世界市場予測(~2022年):ソリューション、サービスThe spear phishing market is projected to grow at a CAGR of 10.8% between 2017 and 2022 The spear phishing market is projected to grow from an estimated USD 840.7 million in 2017 to USD 1,401.6 million by 2022, at a CAGR of 10.8% between 2017 and 2022. Organizations rely heavily on spear phishing solutions whereby filtering spam, data loss prevention, email encryption, and email archiving proves b …
- 世界主要国の肺炎検査(医療機器)市場:サプライヤーシェア及び市場予測The report presents a detailed analysis of the Pneumonia diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Pneumonia definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Comm …
- 糖尿病治療薬の世界市場及びパイプラインインサイト:1型糖尿病、2型糖尿病、糖尿病性足部潰瘍、糖尿病黄斑浮腫、糖尿病性胃アトニー、糖尿病網膜症Diabetes market is a rapidly growing segment with numerous products at different stages of clinical pipeline and others at different phases of industry life cycle. Disease incidences are escalating rapidly across the globe due to which high unmet demand has been created and pharmaceutical companies are trying to provide efficient medical care to patients. Large patient base and superior technology …
- 世界のピアノ市場2015Global Piano Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Piano industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Piano market analysis is provided for the international markets including development trends, competitive landscape analysis, and …
- LTEインフラ市場:ベンダー、市場シェア、主要トレンド及び予測(The LTE Infrastructure Market: Vendors, Market Share, Key Trends & Forecasts)As of Q4 2011, thirty eight mobile network operators worldwide had launched fourth-generation (4G) Long Term Evolution (LTE) networks commercially. Despite a slow ramp and spending stall on overall cellular network infrastructure in 2011, the industry is witnessing sustainable spending acceleration for the LTE wireless infrastructure equipment. Key drivers are higher data speeds of up to 20 Mbps, …
- バルブの世界市場(~2019)The expansion of the global valve industry is forecast to reach 3.9% p.a. in the coming years. Between 2008 and 2014 the market increased with an average annual growth of 7.8%. Currently, oleohydraulic and pneumatic transmissions valves account for 45.6% of the global demand while the remaining market share is divided between relief and safety valves (21.4%), pressure-reducing valves (17.2%) and c …
- 使い捨て保護服の世界市場:材料別(ポリエチレン、ポリプロピレン、ポリエステルなど)、用途別(熱、機械、化学、放射線、その他)、最終用途産業別(製造、石油およびガス、ヘルスケア、防衛、その他)The global disposable protective clothing market was valued at $2,604.0 million in 2018 and is projected to reach $4,686.8 million by 2026, growing at a CAGR of 6.80% from 2019 to 2026. Protective clothing refers to various suits and uniforms worn to protect the user from harm. Protective clothing protects the personnel from physical, electrical, heat, chemicals, biohazards, and airborne particula …
- ライノウイルス検査の世界市場2015The report presents a detailed analysis of the Rhinovirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Rhinovirus definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments: - Hospitals &n …
- 皮膚科装置の世界市場分析:タイプ別(イメージング、皮膚鏡、光線療法、レーザー、脂肪吸引)、用途別(皮膚がん、脱毛、にきび、しわ除去、脂肪除去、色素性病変除去)、セグメント予測、2014-2025The global dermatology devices market is expected to reach a value of USD 25.7 billion by 2025, according to a new report by Grand View Research, Inc. Dermatology devices are expected to grow at a faster rate due to rising concern amongst people regarding esthetics. This has led to rising awareness about various types of esthetic procedures used for treating hair- and skin-related disorders. Prima …
- 切削工具用インサートの世界市場ABSTRACTAbout Cutting Tool Inserts The cutting edge in the cutting tool consists of a separate piece of material called a tool insert, which is either brazed or clamped on the tool body. The insert is generally made of materials such as carbide, CBN, and ceramic inserts. Technavio’s analysts forecast the global cutting tool inserts market to grow at a CAGR of 8.83% during the period 2017-2021. [Co …
- Electricity Supply Board:発電所及びSWOT分析2013Electricity Supply Board - Power Plants and SWOT Analysis, 2013 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services. Scope - Major Power Plants (assets) - summarize …
- 医療産業向けBPO(ビジネスプロセスアウトソーシング)の世界市場予測(~2021)The healthcare BPO market is projected to reach USD 276.79 Billion by 2021 from USD 170.47 Billion in 2016, growing at a CAGR of 10.2% during the forecast period (2016–2021). The pressure to reduce healthcare delivery costs, consolidation of healthcare systems, enactment of PPACA, stringent regulatory requirements, and complex clinical trial protocols are the major drivers for the healthcare BPO m …
- グローバルにおける火力発電所の刷新及び現代化Renovation and Modernization of Thermal Power Plants Summary Renovation and Modernization (R&M) refers to a set of activities intended to improve the performance and reliability of existing power-generation facilities, and is a cost-effective alternative to increasing the operational life of Thermal Power Plants (TPP). Through R&M, obsolete generation equipment undergoes technological upgrades to …